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We introduce a model checking approach to diagnose the emerging of bone pathologies. The imple-
mentation of a new model of bone remodeling in PRISM has led to an interesting characterization
of osteoporosis as a defective bone remodeling dynamics with respect to other bone pathologies.
Our approach allows to derive three types of model checking-based diagnostic estimators. The first
diagnostic measure focuses on the level of bone mineral density, which is currently used in medical
practice. In addition, we have introduced a novel diagnostic estimator which uses the full patient
clinical record, here simulated using the modeling framework. This estimator detects rapid (months)
negative changes in bone mineral density. Independently of the actual bone mineral density, when
the decrease occurs rapidly it is important to alarm the patient and monitor him/her more closely to
detect insurgence of other bone co-morbidities. A third estimator takes into account the variance of
the bone density, which could address the investigation of metabolic syndromes, diabetes and cancer.
Our implementation could make use of different logical combinations of these statistical estimators
and could incorporate other biomarkers for other systemic co-morbidities (for example diabetes and
thalassemia). We are delighted to report that the combination of stochastic modeling with formal
methods motivate new diagnostic framework for complex pathologies. In particular our approach
takes into consideration important properties of biosystems such as multiscale and self-adaptiveness.
The multi-diagnosis could be further expanded, inching towards the complexity of human diseases.
Finally, we briefly introduce self-adaptiveness in formal methods which is a key property in the reg-
ulative mechanisms of biological systems and well known in other mathematical and engineering
areas.
1 Introduction
To our knowledge in the state of the art of formal methods there is no significant results for a multiscale
verification, self-adaptiveness and control. Since these properties are at the core of biological processes
and they are considered in modern systems biology and translational medicine, here we briefly discuss
the potential of developing model checking for translational medicine, by incorporating self-adaptiveness
and multi-level properties. In engineering, physics, meteorology, medicine, biology, social science and
computer science, multiscale modeling is the field of solving physical problems which have important
features at multiple scales, particularly multiple spatial and(or) temporal scales. The self-adaptiveness is
a feature that allows a system to verify properties, predict a new behavior, then to control the system, it
changes the current behavior by adapting to a new situation.
Throughout life, the skeleton is continuously renewed by bone remodeling, a process which serves
the purpose of repairing damaged bone and adapting the skeleton to changes in physical load. Therefore,
the bone is a complex, multiscale process in which genetic mutations manifest themselves as functional
changes at the cellular and tissue scale. The multiscale nature of bone requires mathematical modeling
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approaches that can handle multiple intracellular and extracellular factors acting on different time and
space scales. Previous work has focused on a Shape Calculus [4, 3] approach to bone remodeling [13]. In
this paper new models provide a way to integrate both discrete and continuous behavior that are used to
represent individual cells (as agents) and concentration or density fields (as environment), respectively.
Each discrete cell can also be equipped with sub-models that drive cell behavior in response to micro-
environmental cues. Moreover, the individual cells (i.e. agents) can interact with one another to form
and act as an integrated tissue.
1.1 Bone pathologies altering the bone remodeling process
There are two main types of bone tissue: a compact, hard tissue which forms the outer shell of the bones
and is organized in concentric layers; a second type, termed cancellous or spongy is located beneath the
compact bone and consists of a meshwork of bony bars (trabeculae) with many interconnecting spaces
containing bone marrow which has hematopoietic activity. Bone mass increases with growth in the first
decades of life, and around the age of 30 years the peak bone mass is reached. Thereafter, as a result of
mechanisms involving bone remodeling, very often a net bone loss is seen.
In order to maintain the mechanical properties of the bones, old bone is continuously replaced by
new tissue [14]. However, pathological conditions can alter the equilibrium between bone resorption and
bone formation; osteoporosis, and often osteomyelitis and bone cancer, are examples of pathologies with
negative remodeling: the resorption process prevails on the formation one and this reduces bone density,
so increasing the risk of spontaneous fractures and delaying the recovery.
At the basis of the bone remodeling process there is the activity of populations of cells, namely os-
teoclasts and osteoblasts organized in Basic Multi-cellular Units (BMUs). Osteoblasts (the “fillers”),
which derive from pre-osteoblasts in the blood, follow osteoclasts (the “diggers”) in a highly coordi-
nated manner indicating that a coupled regulative mechanism must exist. Most of the osteoblasts will
become osteocytes, another type of bone cell forming a network embedded in the bone matrix and able
to mechanosensing micro-fractures and to send signals to the BMU cells. This process is highly dynamic
and each BMU has a finite lifetime, so new units are continuously forming as old units are finishing [10].
In the normal bone, the number of BMUs, the bone resorption rate, and the bone formation rate are all
relatively constant depending on hormones, vascularization and genetics [17]. In cortical BMUs, osteo-
clasts excavate cylindrical tunnels in the predominant loading direction of the bone. They are followed
by osteoblasts, filling the tunnel, creating secondary osteons of renewed tissue.
The RANK/RANKL/OPG signaling pathway plays an important role in bone metabolism. RANK is
a protein expressed by osteoclasts and acts as a receptor for RANKL, a protein produced by osteoblasts.
RANK/RANKL binding induces osteoclast differentiation, proliferation and activation. Osteoprotegerin
(OPG) is a decoy receptor for RANKL. It is expressed by mature osteoblasts and it binds with RANKL,
and preventing it from binding to RANK. In this way, OPG inhibits the production of osteoclasts, thus
protecting bone from excessive resorption. The relative concentration of RANKL in bone is a major
determinant of bone mass and strength [8]. In particular, recent works show that the levels of OPG and
RANKL are inversely related to bone density, and may lead to the development of osteoporosis [9].
Our previous work [15] shows how small changes in RANKL for very long periods lead to dis-
ease conditions, especially when aging factors are involved. In particular, we have simulated the bone
remodeling process, defining two subsets in parameter space:
• healthy configuration, where RANKL production and cellular activity is normal, and an
• osteoporotic configuration, with an overproduction of RANKL and a reduced cellular activity.
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Figure 1: Multiscale representation of human femur
In this setting, the overproduction of RANKL is indicative of an inflammation or of hormonal imbalance,
and the lower cellular activity is typical for older people. In the osteoporotic case, higher values of
RANKL promote a higher osteoclastic activity, leading to a higher resorption. Moreover, the reduced
osteoblastic activity is not sufficient to completely repair the consumed part of bone. This causes a bone
density net loss, weakening trabeculae and consequently causing micro-fractures in osteoporotic patients.
Note that in a young patient, an overproduction of RANKL doesn’t determine a disease situation. In fact,
an unexpected high resorption activity can be easily balanced by recruiting more osteoblasts, which is
not possible in an old patient. On the other hand, with normal RANKL concentrations, fewer osteoclasts
are balanced by even fewer osteoblasts (see Figure 2 for a comparison of bone mineral density in healthy
and osteoporotic conditions).
The remainder of the paper is organized as follows. In Section 2 we provide a PRISM model for bone
remodeling. In Section 3 we discuss the self-adaptiveness in biological systems, and the potentialities
for translational medicine modeling. Finally we draw some conclusions and sketch possible future work.
2 A PRISM Model for Bone Remodeling
Here we will formally assess the differences in bone density by evaluating the dynamics of the bone
remodeling process being in a certain state. This kind of data can be elaborated by means of automatic
verification procedures [11]. We believe that this kind of quantitative, formal and automated analysis
may represent a step ahead in the understanding of the modeling efforts of osteoporosis development, by
shifting the attention from an informative, but empirical, analysis of the graphs produced by simulations
towards more precise quantitative interpretations.
Many models describing the behavior of dynamical systems, like distributed and concurrent com-
putational systems, have been equipped with a formal semantics that precisely describes the possible
evolution of the system. Often, such a semantics is given in terms of a Transition System that defines the
possible states of the modeled systems and the modalities to move from one state to another. Recently
model checking methods have been introduced in the analysis of genetic networks; here we further ex-
tend to cell networks and translational medicine. Model checking is perhaps one of the most established
“proof” techniques in symbolic reasoning. The concept of proof gets instantiated appropriately through
an automatic search for a property (specified as a logical formula) to hold or not over a finite set of states.
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Figure 2: Bone density distribution in healthy and osteoporotic patients (from literature). Our model
considers that healthy and osteoporotic patients have slightly different parameter space.
The outcome of model checking is either an affirmative answer or a counter example, e.g. a set of states
representing possible evolutions of the system that do not fulfill the formula.
2.1 Probabilistic Model Checking and PRISM
Probabilistic model checking is a variant of classical model checking techniques and it is typically used
when the system to model exhibits a random or probabilistic behavior. Its output is not simply an affirma-
tive or a negative answer, but it allows to verify quantitative properties over the model: instead of “will
the system eventually reach a particular state?”, we can verify properties like “what is the probability
that the system eventually reach a particular state?”.
Probabilistic verification techniques have proved to be particularly suitable in the analysis of bio-
logical systems, which are intrinsically random and stochastic. Living cells are complex mixtures of a
variety of complex molecules that are constantly undergoing reactions with one another, and such reac-
tions typically have an exponential distribution associated [7]. Furthermore, stochastic fluctuations play
a key role in biological processes, both at the molecular level, where low intracellular copy numbers of
molecules can fundamentally limit the precision of gene regulation e.g. in gene expression dynamics;
and at the macroscopic level, e.g. driving the cells’ phenotypic state. In the process of bone remodeling,
the statistical fluctuations in RANKL concentrations in the blood produce changes in the chemotaxis,
i.e. the process by which cells move toward attractant molecules, of osteoclasts and osteoblasts. This
may affect for example the cell differentiation, number and arrival time, and consequently the whole
remodeling process, as explained in Section 1.1.
In probabilistic model checking models are enriched with quantitative information, i.e probabilities
or stochastic rates, representing the “propensity” with which a certain transition occurs. Such quantities
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affect the stochastic dynamics as expected, since dynamics is ruled by the law of mass action, as standard
(according to this law, the strength of a reaction, its probability to occur quickly say, depends on the
associated rates and the amount of entities ready to participate into the reaction). Typical modeling
techniques are Markov chains and Markov decision processes. Logical formulas are equipped with
quantities as well, and their execution returns a probability or a reward value instead of a boolean value.
In this work we have adopted the open-source PRISM probabilistic model checker [11], one of the
reference model checkers for the analysis of stochastic and probabilistic systems. PRISM models are
specified in a formal language that describes the entities present in the model as modules. Each module
is characterized by a set of state variables and a list of guarded and stochastic commands. Then, the tool
builds the concrete model from the PRISM specification. Currently the following models are supported:
discrete-time Markov chains, continuous-time Markov chains, Markov decision processes, probabilistic
automata, and probabilistic timed automata.
The PRISM model checker have been successfully employed in a several number of biological case
studies, especially for modeling biochemical pathways [12, 6, 2, 16]. However, our framework is not
determined by the features of a specific tool, and other similar platforms could have been chosen.
2.2 Definition of the model
In our settings, we use Continuous Time Markov Chains (CTMC), and the involved entities, or modules
are osteoclasts and osteoblasts. Each state typically consists of the values of the local and global variables
of the model, which keep trace of the amount and variations of involved entities. Listing 1 shows the
PRISM code for bone remodeling. We employ a population-based approach: a state of the system is
characterized by the number of osteoclasts (variable Oc) and osteoblasts (variable Ob) and by their status,
that determines whether they are precursors or mature cells (lines 8 and 17). In order to cope with the
state-explosion problem, we do not consider the actual concentrations of osteoclasts (≈ 10 cells/BMU)
and osteoblasts (≈ 1000 cells/BMU). We rather consider a sub-volume of the BMU, characterized by
smaller ranges: 0−5 for Oc and 0−100 for Ob.
As mentioned in 1.1, a reduced cellular activity and an overproduction of RANKL could be the main
causes of osteoporosis. We model these two factors as parameters, aging and rankLrate, by varying
which we can run and analyze
• a healthy configuration: aging = 1, rankLrate = 0.1, and
• a sick configuration: aging = 2, rankLrate = 0.2.
Then, several possible actions, corresponding to the participation to a reaction, are defined. Each consists
of a name, a guard, a rate and an effect. In the multicellular settings of our model, actions can trigger
an internal state change (e.g. cell differentiation), or can synchronize with other actions in order to
express cellular signaling mechanisms (e.g. pre-osteoclasts’ proliferation induced by pre-osteoblasts).
Resorption and formation are also implemented as actions, and the quantity of bone consumed or formed
is computed by using a transition reward on those actions. On the one hand, the reward structure allows
us to express real-valued bone densities, with respect to state variables which can only assume discrete
values. On the other hand, we keep a lightweight model, since rewards do not increment the state space
differently from variables.
In the initial state, osteoclasts and osteoblasts are precursors (pc:bool init true; pb:bool
init true;). At this point, pre-osteoblasts proliferate linearly (line 18) and after they have reached
a concentration threshold, they start producing RANKL, by performing an action [rankl] (line 19).
RANKL triggers pre-osteoclasts’ proliferation by synchronizing on [rankl] (line 9).
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Then, pre-osteoclasts can become mature osteoclasts (line 10) and start consuming bone with the
[resorb] action (line 11). After each [resorb] action, an osteoclast dies and this induces the matu-
ration of pre-osteoblasts (line 20). Mature osteoblasts mineralize bone (line 21) and similarly to osteo-
clasts, each [form] action causes the death of an osteoblast. Once the concentration of osteoclasts and
osteoclasts is null, they turn back into precursors and the remodeling cycle starts again.
1 c o n s t d ou b l e a g i n g ;
2 c o n s t d ou b l e r a n k L r a t e ;
3 c o n s t d ou b l e formRate = 0 . 0 3 / a g i n g ;
4 c o n s t d ou b l e r e s o r b R a t e = 5∗ r a n k L r a t e / a g i n g ;
5
6 module o s t e o c l a s t s
7 Oc : [ 0 . . 5 ] i n i t 0 ;
8 pc : boo l i n i t t r u e ;
9 [ r a n k l ] pc= t r u e & Oc<5 −> Oc + 0 . 1 : ( Oc’=Oc+1) ;
10 [ ] pc= t r u e & Oc>1 −> 1 : ( pc ’= f a l s e ) ;
11 [ r e s o r b ] pc= f a l s e & Oc>0 −> r e s o r b R a t e ∗pow ( Oc , 2 ) : ( Oc’=Oc−1) ;
12 [ ] pc= f a l s e & Oc=0 −> 1 : ( pc ’= t r u e ) ;
13 endmodule
14
15 module o s t e o b l a s t s
16 Ob : [ 0 . . 1 0 0 ] i n i t 1 ;
17 pb : boo l i n i t t r u e ;
18 [ ] Ob>0 & Ob<100 & pb= t r u e −> pow ( Ob , 0 . 5 ) : ( Ob’=Ob+1) ;
19 [ r a n k l ] pb= t r u e & Ob>50−> r a n k L r a t e ∗Ob : t r u e ;
20 [ r e s o r b ] pb= t r u e −> 1 : ( pb ’= f a l s e ) ;
21 [ form ] Ob>0 & pb= f a l s e −> fo rmRate∗Ob : ( Ob’=Ob−1) ;
22 [ ] pb= f a l s e & Ob=0 −> 1 : ( pb ’= t r u e ) & ( Ob’ = 1 ) ;
23 endmodule
24
25 r e w a r d s ” boneResorbed ”
26 [ r e s o r b ] t r u e : r e s o r b R a t e ;
27 e n d r e w a r d s
28
29 r e w a r d s ” boneFormed ”
30 [ form ] t r u e : fo rmRate ;
31 e n d r e w a r d s
Listing 1: Core PRISM model for bone remodeling
2.3 Definition of the properties
In this work we are interested in analyzing and verifying some crucial properties of the model, and com-
pare the results between healthy and pathological scenarios over a time lapse of four years, which is
enough to assess the presence of bone diseases. We do not focus on cellular properties (e.g. the prob-
ability that osteoclasts are mature at a given time), but rather we aim to verify the emerging properties
of the bone tissue (e.g. the rapidity of negative remodeling) which are more relevant from a clinical per-
spective. In particular, we introduce a statistical estimator based on bone mineral density which reflect
the tissue level. A second estimator detects rapid (months) decreases. This estimator could derive from
different cofactors (morbidity), for example diabetes or cancer. It is therefore more linked to disruptions
at the level of cell-cell interaction and abundances. A third estimator takes into account the variance of
the bone density. The variability of the bone density could address the investigation of metabolic syn-
drome, diabetes and cancer. The logical properties to verify have been formulated in CSL (Continuous
Stochastic Logic) [1], and are:
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• The cumulative values of bone formation and resorption.
f+(t) : R{“boneFormed′′}=?[C ≤ t],
f−(t) : R{“boneResorbed′′}=?[C ≤ t], t = 0,10, . . . ,1460.
The results of the verification for the healthy and the osteoporotic case are displayed in Figure 3.
Note that in normal conditions the disruptive and constructive activities grow with the same mag-
nitude, while in disease conditions resorption increase more quickly than formation.
• The progress of bone density, intended as the difference between bone formation and bone resorp-
tion.
fBD(t) : f+(t)− f−(t), t = 0,10, . . . ,1460.
Figure 4 shows how in the healthy case the bone mass tends to a steady level, differently from the
osteoporotic case where bone mass decreases linearly.
• We are interested to verify not only the expected values of bone mass, but also the variance of bone
density with respect to the values from each state, at t = 365 (1 year), t = 730 (2 years), t = 1095
(3 years), and t = 1460 (4 years). Since we are working with rewards, we cannot express this
property with a P-formula, but we are able to compute the states satisfying this property. We make
use of PRISM filters, a particular kind of formulas capable to compute values simultaneously for
several states. Filters are of the form
f ilter(op, prop,states),
where op is the operator characterizing the type of filter (max, min, avg, range, count, . . . ); prop
is the PRISM property to verify; and states is the predicate identifying the set of states over which
to apply the filter (if true it can be omitted). In order to compute all the density values from all the
states, we make use of the print filter, a particular operator that prints in the PRISM log each state
and the value from prop.
f ilter(print, fBD(t)< d), t = 365,730,1095,1460 d =−5,−4.5, . . . ,4.5,5.
The curves in Fig. 5 are the normal distributions with average and variance computed from the
values outputted by PRISM. The results clearly show that in the healthy case the bone density is
mainly distributed in the interval [0,2]. While in the osteoporotic case, the negative bone density
gets worse and sharper as the years go by.
• Finally, we consider the rapidity of negative changes in bone mass as a valuable indicator in as-
sessing osteoporosis. In particular we want to verify if the value of bone density decreases of a
quantity k between time t and time t+∆t. The formula is the following.
fBD(t+∆t)+k < fBD(t), t = 0,50, . . . ,1450, k = 0.25,0.50.
Clearly, true results predict alarming rapid changes, which can be monitored in order to prevent
osteoporosis. By increasing the threshold k, we relax the condition so that we obtain a minor
number of true results. On the other hand, the fact that the formula is satisfied with high values of
k indicates a severe bone loss. Table 1 shows the results of this analysis, comparing the healthy
and the osteoporotic case and evaluating rapid negative changes in a time interval ∆t of 100 days.
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Healthy Osteoporotic
Figure 3: Expected values of resorbed and formed bone in 4 years.
Figure 4: Variation in bone density during 4 years.
Similarly, a measure able to predict also rapid positive changes would be useful in medical appli-
cations, for those pathologies characterized by a positive bone metabolism (e.g. bone metastasis).
This measure has been formulated as the difference quotient of bone mineral density:
fBD(t+∆t)− fBD(t)
∆t
, t = 0,50, . . . ,1450.
We have verified this on our model by setting ∆t = 100. Results in Fig. 6 illustrate that in the
healthy case only an initial rapid bone growth is registered (at t = 100, corresponding to the interval
[100,200] days); thereafter the change rate reaches a stationary level close to zero. While in the
osteoporotic case, alarming negative changes are reported around the interval [0,300] days. Then,
the curve tends to a steady level, even if the rate change is negative, confirming the net bone loss
of the osteoporotic series in Fig. 4.
2.4 A verification-driven diagnosis
Figure 7 illustrates the density values of the trabeculae computed in the simulation of the two config-
urations, during the resorption phase (t = 130) and in the last days of the remodeling cycle (t = 350).
While at t = 130 the bone density is approximately the same, at the end of the simulation differences
are quite prominent, since the reduced osteoblastic activity generates several zones with a lower density.
Let assume that the simulation of the PRISM implementation of the model is the analogue of the deter-
mination of clinical parameters during periodic frequent medical visits. This approach suggests that in
the future the determination of the values for certain cell type and signaling molecules concentrations
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Figure 5: Bone density distributions in the years.
(t, t+100) days Healthy Osteoporotic0.25 0.5 0.25 0.5
0 tt f f f f f f
50 f f f f tt f f
100 f f f f tt tt
150 f f f f tt tt
200 f f f f tt f f
250 f f f f tt f f
300 f f f f f f f f
. . . . . . . . . . . . . . .
750 f f f f f f f f
800 f f f f tt f f
850 f f f f tt f f
900 f f f f f f f f
. . . . . . . . . . . . . . .
1450 f f f f f f f f
Table 1: Rapidity of negative remodeling. True values are bad (too rapid negative changes). Rows with
false values in each cell have been omitted.
Figure 6: Difference of bone mineral density. The plot shows the change rate in an interval of ∆t = 100.
Alarming pathological values are below -0.0025 and above 0.0025.
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Figure 7: Bone density during the simulation of healthy (H) and osteoporotic (O) configurations for two
different simulation times (130 and 350 days)
(perhaps measured from gene expression data) will provide means for simulating the progression of the
disease and the efficacy of therapies. Therefore our work is meaningful in perspective of a new type of
medicine characterized by a close coupling between clinical measures and modeling prediction.
We have defined meaningful statistical estimators: a) simple bone mineral density (amount of matter
per cubic centimeter of bones, measured as z-score, the number of standard deviations above or below
the mean for the patient’s age, sex and ethnicity; or as t-score, the number of standard deviations above
or below the mean for a healthy 30 year old adult of the same sex and ethnicity as the patient). This is a
tissue-level estimator.
b) The rate of decrease of bone mineral density during consecutive medical visits. This estimator tells
us the emergence of defects of the bone metabolism in terms of signaling networks of RANK/RANKL
and decrease of pre-osteoblast number. This estimator is at cell and molecular signaling levels.
c) The changes in the variance or in the fractal pattern of the signal (measured using Hurst coefficient,
for example using wavelets). If the variability of the bone density largely increases that pattern could
depend on metabolic syndrome, diabetes, cancer. This could be mainly related to intracellular signaling
disruption. The signal could also change its fractal pattern which could be in general related to a decrease
in signaling responsiveness. Therefore a), b) and c) tell us of different types of disruptions. Note that
there may be dependencies between a), b) and c).
Diagnosis could be different for different combinations of a), b) and c). For example:
• a) OR b) = “osteoporosis or progression to osteoporosis”;
• a) AND b) = “severe osteoporosis with loss of calcium”;
• a) AND c) = “severe decrease of general metabolic functions due to important infection”;
• b) AND c) = “infection (osteomielites) and/or cancer”.
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• d) diabetes AND b) = great risk of progressive osteoporosis;
• e) thalassemia AND b) = great risk of osteoporosis.
Our approach is novel because it provides a complex diagnostic framework which could incorporate
additional biomarkers. Therefore these combinations provide means for multi-disease diagnosis and
multiscale causes identification.
It is noteworthy that also the shape of the trabeculae could be object of property verification. In gen-
eral large part of diagnosis of pathologies depends more on visual inspection and microscopic analysis
of tissues than with molecular markers. Therefore, the Shape Calculus [4, 3] could in principle be used
to assess properties on the shape of the trabeculae.
3 Discussion
The computational modeling of osteoporosis is particularly challenging because the disease could span
several years and decades. Although we have not addressed data fitting with individual patient data, we
have used knowledge derived from literature and held regular meetings with medical scientists at the
Rizzoli Hospital in Bologna for bone diseases which has a prestigious medical record in terms of number
of patients, advanced technology and expertise.
In this work we raise the challenge of effectively applying formal methods in biomedical practice,
showing that probabilistic model checking can be successfully employed in the diagnosis and in the
prediction of complex bone pathologies like osteoporosis. The verification of quantitative properties on
bone density has provided three different statistical estimators: the first one is related to bone mass;
the second one monitors rapid negative (or positive) changes as a symptom of osteoporosis; the third
estimator measures the variance in bone density.
Such estimators have been evaluated over two different subsets of the parameter space of the model,
corresponding to a healthy configuration and an osteoporotic configuration. The results indicate that in
the first case bone homeostasis, i.e. the balance between resorption and formation, is maintained during
the years and that the variance of bone density is delimited to a well-defined interval. On the other
hand in the osteoporotic case, we experience a net bone loss which is constant throughout the years,
also characterized by high peaks of negative change rate. Furthermore we show how more complex
pathologies can be diagnosed by combining these three estimators. Besides being suitable to assess other
types of diseases affecting bone remodeling, our approach represents an innovative diagnostic framework
which can be of inspiration for a new type of medicine which combines clinical measures and modeling
predictions.
As future work, a desired direction would be reverse engineering from patient datasets, which in turn
will allow to fine tuning the diagnosis. In addition, we aim at using parametric probabilistic model repair
techniques [5] for our model. The problem of model repair is, roughly speaking, “given a probabilistic
model M and a formula not satisfied by M, finding a M′ that satisfy the formula and such that the cost
of modifying M to obtain M′ is minimized”. Consider our model of bone remodeling, and a formula for
checking if the system will reach a required bone density. Suppose that the formula is not satisfied, as in
an osteoporotic patient. The idea is that parametric model repair can automatically suggest the minimal
changes to adopt in the parameters (e.g. RANKL or cellular activity) such that the system can reach that
desirable bone density. We believe that this could be the key for the next-generation medical treatments.
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3.1 Tissue properties verification, “prediction” and control
Now we discuss the self-adaptiveness of biological systems, particularly focusing on the bone remod-
eling process. In self-adaptive systems the next behavior of a component is determined by feedback
information on the environment in which the component itself acts. We show that many biological phe-
nomena intrinsically exhibit a self-adaptive nature, which is closely related to the concepts of regulation
and shape.
Despite bone remodeling occurs asynchronously at various sites, bone shapes and size are strictly
controlled, suggesting that several multiscale controls exist. Therefore bone remodeling is a multi-
level process, where macroscopic (tissue) and microscopic (cellular, molecular) scales are closely inter-
dependent. Generally speaking, in animal biology, the concept of shape is inherently linked to the ex-
istence of control mechanisms and therefore to self-adaptiveness. Tissue homeostasis derives from a
regulation of the relative activities of bone cells, in particular osteoblasts and osteoclasts, which control
bone deposition and resorption, respectively. Bone homeostasis is also regulated through the environ-
ment, could be the internal one, for example hormones (for example parathyroid hormone and vitamin
D, which are the principal modulators in calcium homeostasis) or the external one, for example external
mechanical forces (for example physical activity, radiation such as the case of cancer patients, different
gravity such as the case of astronauts 1).
For many aspects the abstraction of cells, or any autonomous biological entity, could be agents. Fol-
lowing this, we take into account also the environment where cells, as agents, are acting and interacting.
In turn, the environment could be seen as the entity that interacts with the systems (e.g. molecular,
cell, tissue, organ, etc.) incorporated. We can generalize further if we see the environment in terms of
rules that drive the emerging behavior of the whole systems, e.g. the parameters space that affects the
shape of the whole system. We propose a self-adaptive system as a pair of <environment, agent>, the
environment is represented by the parameter space and the functional constraints of the whole system
(e.g. tissue), while the agent (e.g. a cell or set of cell) represents the system that during its dynamics,
changes the parameters values of the environment and thus affects the satisfaction of the constraints.
Generally speaking, an agent is a system that is located in some environments; is capable to perceive
environmental information through his sensors; according to such information it selects the best action;
and finally it acts, through his actuators, on the environment in order to meet its design objectives. With
environment
prediction verification
controller
agent
actuators
sensors
perceptions
actions
Figure 8: Graphical representation of a self-adaptive system
reference to Figure 8 there are several concepts that form a correspondence between the system with
self-adaptiveness and the bone system. First of all, shape maintenance is related to both the species evo-
lution and the organism development, which is termed the evo-devo. The evolutionary basis provides a
1see http://www.sciencedaily.com/releases/2006/07/060717091230.htm
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sort of bone strength “prediction”, encoded in the genome while the development basis represent a sort
of verification related to the conditions of the organism during his life. In the bone remodeling process,
the sensing activities which trigger the control system have also a multiscale nature. In particular, the
osteocytes in the bone matrix sense micro-fractures due to the apoptosis of the cells close to it and to the
disruption of the canaliculi network. The regulative mechanisms operate in a dynamical manner due to
the BR process. Abnormalities in the bone size and shape are therefore related to important pathologies.
Another important biological principle tells us that the structural information (i.e. the shape, size and
orientation) drives the function. This link between the shape and the function in biology defines the
self-adaptive nature of bone remodeling. Hence, the verification of properties on functional disruption
could be used to assess disease severity.
Self-adaptiveness is a common characteristic of biological systems, since it implies the capability
of the involved entities to react properly with respect to the environment in which they are located, and
it implies regulative mechanisms able to ensure critical functional properties (e.g. tissue homeostasis).
Moreover many biological principles such as morphogenesis state that an organism develops its own
shape according to the function, the role it must accomplish. For these reasons, we believe that a shape-
based formal verification may give important insights into many unanswered questions of developmental
biology.
3.2 Potentialities for translational medicine modeling
We stress that multiscale and self-adaptive properties found in biological processes should inspire anal-
ogous properties in formal methods. The modeling of osteoporosis as a bone remodeling disruption is
a prototype translational medicine problem which has offered us several points to discuss how formal
methods should develop in order to provide better answer to the growing field computational medicine.
The multi-level approach allows to manage simultaneously the concept of environmental parameters
(at tissue level) and the concept of agents that interact within an environments (at cellular level). The
cellular interactions, driven by the environmental parameters give as result a change in the parameters
themselves that in turn drive new interactions.
The multi-level analysis, shifted from global to local and vice-versa, helps in monitoring the emerg-
ing of diseases such as the osteoporosis. In the local case, the probabilistic and temporal parameters
should be present in the syntax of the modal operators and the interpretation of the resulting formulas
should be qualitative, in the sense that it should return a truth value, e.g. balance between osteoclasts and
osteoblasts. By contrast, in the global case no probabilistic and temporal parameters should be present in
the syntax but the interpretation of the usual formulas should be quantitative, in the sense that it should
return a number that measures how much a formula is satisfied, e.g. the bone mineral density. The
quantitative analysis is manly based on the bone density, until under a certain threshold no osteoporosis,
while over alert. In the case of no alert, to be sure of the healthy state, a low-level qualitative analysis, at
cellular level, should be employed to verify the balance between osteoclast and osteoblast populations.
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